Training and evaluation data, and trained model checkpoint for the Ensemble-Conditioned Molecular Design research paper
0 citationsZenodo (CERN European Organization for Nuclear Research)
AstraZeneca (United Kingdom)
Cambridge · GB · company
21437Publications signalées
2814190Citations signalées
12Thèmes principaux
Principaux domaines
Lung Cancer Treatments and MutationsComputational Drug Discovery MethodsAsthma and respiratory diseasesPARP inhibition in cancer therapyAnalytical Chemistry and ChromatographyPharmacogenetics and Drug MetabolismChronic Obstructive Pulmonary Disease (COPD) ResearchCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsChemical Synthesis and AnalysisMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer Research
Évolution annuelle
Publications récentes
Training and evaluation data, and trained model checkpoint for the Ensemble-Conditioned Molecular Design research paper
0 citationsZenodo (CERN European Organization for Nuclear Research)
opentargets/OnToma: v2.6.0
Eliseo Papa, Kirill Tsukanov, Vivien Ho, Irene López Santiago et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Treatment patterns and disease burden of hypereosinophilic syndrome (HES) in the United States: A real-world observational, retrospective cohort study
Thanai Pongdee, Paul Dolin, Bo Ding, Amanda M. Moore et autres
0 citationsWorld Allergy Organization Journal
Clinical outcomes by type of surgery with perioperative durvalumab in patients with resectable non-small cell lung cancer
David Harpole, John V. Heymach, Martin Reck, Janis Taube et autres
0 citationsJournal of Thoracic and Cardiovascular Surgery
Longitudinal ctDNA tracking in early and recurrent breast cancer using an ultrasensitive structural variant-based assay: an extended analysis from the TRACER study
Mitchell J. Elliott, J. Roh, T. Bird, M. Li et autres
0 citationsESMO Open
P31-02 Engineering Selective Cereblon Engagement: Mechanistic Insights and Proteome-Wide Off-Target Assessment for Safer Targeted Protein Degraders
M. Rodrigo, I. Michaelides, K. Moreau
0 citationsToxicology Letters
S12-02 Study Design Considerations for Preclinical Safety Assessment of Targeted Protein Degraders
0 citationsToxicology Letters
The mTOR pathway drives daily physiology
Aiwei Zeng, Andrei Mihut, Madhanagopal Anandapadamanaban, Alejandra Goity et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
A modified Delphi consensus on creating a time-clocked care pathway in severe asthma – time is of the essence
M. Bhutani, T. Winders, D. Price, GW Canonica et autres
0 citationsnpj Primary Care Respiratory Medicine
Laboratory animal science cannot afford sex bias: Aligning the 3Rs with sex-inclusive research
Fernando Gonzalez-Uarquin, Paulin Jirkof, Annemarie Lang, Ivana Jarić et autres
0 citationsLaboratory Animals
Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis
Petter Brodin, Fryderyk Wilczynski, Luca Ricci Pacifici, Peter D. Gabb et autres
0 citationsInfectious Diseases and Therapy
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.